(Q37079261)

18 August 2017

1 reference

title

Development of drugs for gastrointestinal motor disorders: translating science to clinical need (English)

1 reference

18 August 2017

G J Sanger

1

1 reference

18 August 2017

D H Alpers

series ordinal

2

1 reference

18 August 2017

publication date

1 March 2008

1 reference

Neurogastroenterology and Motility

18 August 2017

published in

1 reference

18 August 2017

volume

20

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

177-184

1 reference

Promotility medications--now and in the future

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

CRF1 receptors as a therapeutic target for irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Demonstration of functional neuronal beta3-adrenoceptors within the enteric nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Treatment of nausea and vomiting: gaps in our knowledge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Drug Insight: from disturbed motility to disordered movement--a review of the clinical benefits and medicolegal risks of metoclopramide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Differences between the abilities of tegaserod and motilin receptor agonists to stimulate gastric motility in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Influence of motilin on gastric fundus tone and on meal-induced satiety in man: role of cholinergic pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Erythromycin in the short- and long-term control of dyspepsia symptoms in patients with gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Efficacy of prolonged administration of intravenous erythromycin in an ambulatory setting as treatment of severe gastroparesis: one center's experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Insights into opioid action in the intestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Reassessing the benefits and risks of alosetron: what is its place in the treatment of irritable bowel syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Incidence of ischemic colitis and serious complications of constipation among patients using alosetron: systematic review of clinical trials and post-marketing surveillance data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Is there an experimental basis for the development of ischaemic colitis as a result of 5-HT3 antagonist treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Lubiprostone: a chloride channel activator for treatment of chronic constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

The effects of ABT-229 and octreotide on interdigestive small bowel motility, bacterial overgrowth and bacterial translocation in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Prokineticin-2, motilin, ghrelin and metoclopramide: prokinetic utility in mouse stomach and colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Review article: gastric emptying in functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Ghrelin gastrokinetic action in patients with neurogenic gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Effect of ghrelin and growth hormone-releasing peptide 6 on septic ileus in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Ghrelin alleviates cancer chemotherapy-associated dyspepsia in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Physiological, pathological and potential therapeutic roles of ghrelin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

A placebo-controlled trial of itopride in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Distribution of membrane bound guanylyl cyclases in human intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Guanylin family: new intestinal peptides regulating electrolyte and water homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Guanylin regulatory peptides: structures, biological activities mediated by cyclic GMP and pathobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Pathophysiology and treatment of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Dysaccommodation of the stomach: therapeutic nirvana?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Recent insights into digestive motility in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Diet, food intake, and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Impaired gastric emptying and altered intragastric meal distribution in diabetes mellitus related to autonomic neuropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief. Results of a double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Human Pharmacokinetics and Comparative Bioavailability of Loperamide Hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Mechanisms of disease: the pathological basis of gastroparesis--a review of experimental and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2008.01084.X

Pharmacological interventions for non-ulcer dyspepsia

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001960.PUB3

Identifiers

DOI

10.1111/J.1365-2982.2008.01084.X

1 reference

18 August 2017

1 reference